首页> 美国政府科技报告 >Generation of in Vitro Cellular Models of Lymphangioleiomyomatosis for the Development of Tuberous Sclerosis Therapeutics
【24h】

Generation of in Vitro Cellular Models of Lymphangioleiomyomatosis for the Development of Tuberous Sclerosis Therapeutics

机译:淋巴管平滑肌瘤病的体外细胞模型的产生为结节性硬化症的发展

获取原文

摘要

The purposes of this work are three related objectives: to generate human TSC2-/- LAM cell lines; to generate matching inducible isogenic TSC2 knock-in cell lines; and to confirm the absence and rescue of TSC signaling in these LAM lines. We generated 400 immortalized LAM cell lines from two different LAM tissue sources and used immunoblot analysis to determine the loss of the TSC2 protein itself, or function as indicate by phosphorylation of the ribosomal protein S6 in the absence of serum. Despite the fact that the original LAM tissues suggested loss of TSC2 by FISH analysis in a subset of the tissue, none of the newly developed lines appear to be negative for TSC2. We feel, however, that these lines still be valuable to the TSC and LAM communities and we will therefore, disseminate the generated cell lines upon request.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号